Phyton Operates Certified GMP Development and Manufacturing Facilities in Germany and Canada

Phyton Biotech operates the world’s largest Plant Cell Fermentation (PCF®) Technology facility with more than 200,000 litres of fermentation capacity and multiple production lines from kilograms to tonnes of product volumes. With our state-of-the-art facilities, we are uniquely equipped to address the entire development chain, including sourcing/selection of plant material, cell line/fermentation/downstream process development, analytical development, semi-synthesis and scale-up to commercial production.

Europe
PHYTON BIOTECH GERMANY

Ahrensburg, Germany (near Hamburg)

GMP PCF®

Commercial production or starting material for paclitaxel and docetaxel API using Plant Cell Fermentation Technology
Technology Hub for the development of speciality fermentation solutions
North America
PHYTON BIOTECH CANADA

Vancouver, Canada

GMP Finished API

Commercial production of paclitaxel and docetaxel finished API’s
Global regulatory compliance & maintenance of drug master files
Global commercial sales and distribution
Customer support

History and ownership

Phyton was the first company in the world to leverage plant cell fermentation for the development and commercialization of plant-based pharmaceuticals used to treat cancer and other life-threatening illnesses.

Our History

Company values

At Phyton, we are at the forefront of innovation and excellence in harnessing the potential of phytochemicals using “green” biotechnology. Our mission, vision and values have been core to our success for over 25 years and guide our exceptional people every day in everything they do.

our mission, vision & values